ShareThis Page
State lists applicants to grow medical cannabis in Pa. |

State lists applicants to grow medical cannabis in Pa.

| Saturday, June 17, 2017 1:36 p.m
Getty Images
People browse vendors products at the Cannabis World Congress Conference on June 16, 2017 in New York City. Billed as 'the leading trade show and conference for the legalized cannabis, medical marijuana, and industrial hemp industries,' the 4th annual conference brings together dozens of both small and large businesses involved in the growing hemp and marijuana market.
In this Dec. 5, 2013, file photo, marijuana matures at the Medicine Man dispensary and grow operation in northeast Denver.
Colorado marijuana market funds busts of illegal growers
A complete list of companies that want to grow and process medical marijuana in Pennsylvania was released Friday by the state Department of Health. If...

A complete list of companies that want to grow and process medical marijuana in Pennsylvania was released Friday by the state Department of Health.

If all goes as planned, the state will award 12 of the coveted growing permits by the end of June. An announcement of the winners could come as soon as next week.

Two of those permits are slated for Southeastern Pennsylvania, the state’s most populous and potentially most lucrative region, where 51 aspirants are vying to set up growing operations inside warehouses that will be sealed tighter than prisons.

The majority of the applicants are cloaked in mystery. The state issued only a list of company names. It withheld locations of the proposed sites and did not identify the principals involved. The businesses have not had to register with the state. The Department of Health has promised to release details – but only about the winners – when it awards the permits.

Several of the businesses, however, are established entities that operate in other states. Franklin Labs is a partner in the Garden State Dispensary in Woodbridge, N.J.; Palliatech is a publicly traded medical marijuana company based in Massachusetts; Rise Labs principal David Tuttleman is an owner of Matrix NV, a flourishing producer of cannabis in Nevada.

Some of the local aspirants have been public with their intentions and have aligned themselves with established cannabis powerhouses. Snider Health, which wants to build a facility in Northeast Philadelphia, is working with the Clinic, which operates marijuana businesses in Colorado and Illinois. A number of high-profile former sports stars, including Pittsburgh Steelers legend Franco Harris, are seeking roles in Pennsylvania’s budding industry.

The SENTEL Group and Surterra Pennsylvania hedged their bets and applied for permits in several Keystone State locations. There is no readily available information about SENTEL online. Surterra appears to run a marijuana farm in Florida.

More than two dozen states and the District of Columbia have passed medical cannabis laws. Four of those jurisdictions – Colorado, Oregon, Alaska, and the nation’s capital – allow adult recreational use.

Gov. Wolf last year signed a bill that will make medical marijuana available in 2018, when doctors will be able to recommend cannabis-infused oils to patients. Qualifying ailments include autism, cancer, intractable pain, multiple sclerosis, and post-traumatic stress disorder, among a dozen other conditions.

The list of the 400 companies that applied to grow in Pennsylvania can be found here .

TribLIVE commenting policy

You are solely responsible for your comments and by using you agree to our Terms of Service.

We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.

While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.

We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers

We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.

We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.

We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.

We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.